Commentary on “Deep Brain Stimulation for Treatment-Refractory Depression”
AbstractMajor depressive disorder is a chronic, disabling, and potentially life-threatening disorder that has a lifetime prevalence of 15% to 20%. A 2015 article published in Lancet evaluating the global burden of disease ranked major depressive disorder as the second leading cause of disability in 2013, contributing to 51,784 disability-years.1 Although various treatment modalities, including antidepressants, adjunctive medications, psychotherapy, and electroconvulsive therapy have been developed, many individuals continue to experience clinical symptoms and few experience complete remission.
This content is limited to qualifying members.
If you have an existing account please login now to access this article or view your purchase options.
Create a free account, then purchase this article to download or access it online for 24 hours.
Create a free account, then purchase a subscription to get complete access to all articles for a full year.